Clinical Trials

42 enrolled 11 charts

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02366663 2018-03-12

SPINOZA

Phase 3 Terminated

3 enrolled 8 charts

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00644371 2017-03-27

Z-RIC-Allo

20 enrolled

Lymphoma, Lymphoma, Non-Hodgkin

NCT00062114 2016-07-06

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

84 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00646750 2016-02-15

Z-BEAM LDGGB

31 enrolled

Lymphoma, Lymphoma, Non-Hodgkin

NCT00438880 2016-02-04

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Phase 1/2 Completed

38 enrolled 8 charts

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Phase 2 Withdrawn

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

NCT00005592 2015-10-21

Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

23 enrolled

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00319332 2015-04-17

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Phase 3 Withdrawn

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00220285 2014-12-30

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

45 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

Phase NA Completed

12 enrolled 3 charts

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT00521560 2013-02-15

escZ-BEAM

28 enrolled

Phase EARLY_PHASE1 Completed

Lymphoma, Non-Hodgkin

NCT00017381 2013-01-09

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

30 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00463463 2012-07-12

Zevalin

Phase 3 Unknown

Lymphoma, Non-Hodgkin

NCT00186589 2012-06-06

90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL

Phase 1 Completed

30 enrolled

Lymphoma, Non-Hodgkin

NCT00058292 2012-06-01

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1 Completed

44 enrolled

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01479387 2011-11-24

ZEVALIN-SDUI

Completed

72 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT00193440 2010-12-30

Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma

40 enrolled

Lymphoma, Non-Hodgkin

NCT01164696 2010-08-24

A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin

Completed

30 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00354822 2009-09-18

Z0105

Phase 2 Terminated

25 enrolled

Lymphoma, Non-Hodgkin

NCT00807196 2008-12-11

Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

Phase 1/2 Unknown

20 enrolled

Lymphoma, Non-Hodgkin

NCT00438581 2007-02-27

Zevalin

Phase 2 Unknown

40 enrolled

Lymphoma, Non-Hodgkin

NCT00057343 2006-09-12

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Phase 3 Terminated

400 enrolled